PM Modi chairs high-level Covid meet, urge states to ensure O2 availability

States are being asked to maintain a buffer stock for drugs used in management of COVID-19, mucormycosis, MIS-C at the district level

PM Modi
PM Modi underscored the need to rapidly augment the entire ecosystem to ensure increased oxygen availability, including oxygen concentrators, cylinders and PSA plants
Press Trust of India New Delhi
3 min read Last Updated : Sep 11 2021 | 1:17 AM IST

Prime Minister Narendra Modi on Friday chaired a high-level meeting on the Covid situation and vaccination as the government noted high caseloads in states like Kerala and Maharashtra to say that there can be no room for complacency.

Modi reviewed the status of augmentation of bed capacity for pediatric care and of facilities supported under "COVID Emergency Response Package II", and it was noted that states have been advised to redesign and orient primary care and block level health infrastructure in these areas to manage the situation in rural areas, a statement said.

States are being asked to maintain a buffer stock for drugs used in management of COVID-19, mucormycosis, MIS-C at the district level, it added.

"It was discussed that across the world, there are countries where the number of active Covid cases continues to remain high. In India too, the figures from states like Maharashtra and Kerala indicate that there can be no room for complacency," the statement said.

However, the weekly positivity was at less than three per cent for the 10th consecutive week, it added.

Modi underscored the need to rapidly augment the entire ecosystem to ensure increased oxygen availability, including oxygen concentrators, cylinders and PSA plants.

Efforts are also on to install 961 Liquid Medical Oxygen storage tanks and 1,450 medical gas pipeline systems with an aim to support at least one such unit per district, the government said.

The ambulance network is also being augmented to ensure at least one ambulance per block.

Modi also reviewed the status of PSA oxygen plants coming up across the country and told that around one lakh oxygen concentrators and three lakh oxygen cylinders have been distributed to states.

He was also briefed about the concentration of cases in a few geographies, districts with high test positivity as well as the week on week test positivity rate in the country.

On vaccines, the statement noted that around 58 per cent of India's adult population has received the first dose and nearly 18 per cent both doses.

Modi was also updated about the vaccine pipeline and increased supply of vaccines.

He spoke about the need for constant genome sequencing to monitor emergence of mutants.

He was informed that INSACOG (SARS-CoV-2 Genomic Consortium) now consists of 28 labs distributed across the country.

The lab network is also linked with a hospital network for clinical correlation. Sewage sampling is also being done for genomic surveillance. States have been requested to share SARS COV2 positive samples with INSACOG regularly.

Modi highlighted the need to ensure adequate testing across the country and was told about the support being given to 433 districts to establish RT-PCR lab facility in public health facilities.

The principal secretary to the prime minister, cabinet secretary, principal scientific advisor, health secretary, member (health) NITI Aayog and other important officials were present in the meeting.

The meeting came a day after Union Health Secretary Rajesh Bhushan said India is still going through the second wave of COVID-19 and it is not over yet.

He had said 35 districts are still reporting a weekly Covid positivity rate of over 10 per cent while it is between five and 10 per cent in 30 districts.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusNarendra ModiCoronavirus TestsHealth MinistryOxygen

First Published: Sep 10 2021 | 11:19 PM IST

Next Story